The goal of the project EVOMET is to train 15 young researchers in the understanding of metastastic processes and their evolution, with the aim to identify therapeutic solutions.

Coordinated by IRB Barcelona, Evomet -    The Evomet consortium is formed by 13 institutions, which include several of the best academic, clinical and industrial centres working in cancer research and metastasis research in Europe.  
Among beneficiaries : Stem Cells and Cancer  Laboratory - Faculty of Medicine - led by Cédric Blanpain – and spin-off company ChromaCure.

The Evomet project has received €4 M and will last for four years.

This project has received funding from the European Union - Innovative training Network Marie Sklodowska-Curie – Grant agreement N° 955951.
Created on September 8, 2020